Stay updated on Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial
Sign up to get notified when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.
Latest updates to the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page
- CheckyesterdayChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference1%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe website has added new features while removing detailed options for participant groups, interventions, and various data fields for downloads.SummaryDifference2%
- Check22 days agoChange DetectedSeveral key resources related to HIV and clinical trials have been removed, including links to MedlinePlus and multiple PubMed articles.SummaryDifference0.3%
- Check30 days agoChange DetectedThe website has been updated to version v2.12.2, adding numerous links to clinical trial documents and PubMed articles, while removing the previous version v2.12.1.SummaryDifference3%
- Check37 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.0%
- Check44 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential improvements or features.SummaryDifference0.1%
Stay in the know with updates to Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.